Anthracene-based inhibitors of dengue virus NS2B-NS3 protease

Keyphrases

• Inhibitory Activity 100%
• Dengue Virus 100%
• NS2B-NS3 Protease 100%
• Anthracene 100%
• Dengue Protease 66%
• Dengue Fever 66%
• Structure-activity Relationship 66%
• Illness 33%
• Health Systems 33%
• Developing Nations 33%
• Cell Culture 33%
• Virus Replication 33%
• Developed Countries 33%
• Antiviral Activity 33%
• Kinetic Analysis 33%
• Viral 33%
• Dengue 33%
• Antiretroviral Therapy 33%
• Vaccine Therapy 33%
• Protease Activity 33%
• Protease Inhibitors 33%
• Dengue Infection 33%
• Mandatory Vaccines 33%
• Recent Outbreaks 33%
• Functional Groups 33%
• Australia 33%
• Dengue Shock Syndrome 33%
• In Vitro Activity 33%
• Antiviral Drug Development 33%
• France 33%
• Tropical Region 33%
• Subtropical Region 33%
• Mosquito-borne Flavivirus 33%
• Dengue 2 33%
• Significant Disease 33%
• Inhibition Assay 33%
• Taiwan 33%
• Global Health Care 33%
• Detailed Chemical Kinetics 33%
• Proteasome Inhibition 33%
• Protease Complex 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Proteinase 100%
• Dengue Virus 100%
• Dengue 100%
• Anthracene 100%
• Structure Activity Relationship 50%
• Diseases 50%
• Antivirus Agent 25%
• Cell Culture 25%
• Drug Development 25%
• Antiviral Activity 25%
• Virus Infection 25%
• Antiviral Therapy 25%
• Flavivirus 25%
• Proteinase Inhibitor 25%
• Functional Groups 25%
• Lead Compound 25%
• Proteasome 25%
• Dengue Hemorrhagic Fever 25%
• Dengue Shock Syndrome 25%

Biochemistry, Genetics and Molecular Biology

• Dengue Virus 100%
• Protease 100%
• Structure Activity Relation 50%
• Virus Replication 25%
• Cell Culture 25%
• Antiviral Activity 25%
• Flavivirus 25%
• Protease Inhibitor 25%
• Proteasome 25%
• Proteinase Inhibition 25%
• Drug Development 25%